Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury
- PMID: 26004679
- DOI: 10.1016/j.neuroscience.2015.05.036
Acute administration of ucf-101 ameliorates the locomotor impairments induced by a traumatic spinal cord injury
Abstract
Secondary death of neural cells plays a key role in the physiopathology and the functional consequences of traumatic spinal cord injury (SCI). Pharmacological manipulation of cell death pathways leading to the preservation of neural cells is acknowledged as a main therapeutic goal in SCI. In the present work, we hypothesize that administration of the neuroprotective cell-permeable compound ucf-101 will reduce neural cell death during the secondary damage of SCI, increasing tissue preservation and reducing the functional deficits. To test this hypothesis, we treated mice with ucf-101 during the first week after a moderate contusive SCI. Our results reveal that ucf-101 administration protects neural cells from the deleterious secondary mechanisms triggered by the trauma, reducing the extension of tissue damage and improving motor function recovery. Our studies also suggest that the effects of ucf-101 may be mediated through the inhibition of HtrA2/OMI and the concomitant increase of inhibitor of apoptosis protein XIAP, as well as the induction of ERK1/2 activation and/or expression. In vitro assays confirm the effects of ucf-101 on both pathways as well as on the reduction of caspase cascade activation and apoptotic cell death in a neuroblastoma cell line. These results suggest that ucf-101 can be a promising therapeutic tool for SCI that deserves more detailed analyses.
Keywords: HtrA2/OMI; XIAP; apoptosis; neuroprotection; pERK1/2; spinal cord.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Simvastatin inhibits neural cell apoptosis and promotes locomotor recovery via activation of Wnt/β-catenin signaling pathway after spinal cord injury.J Neurochem. 2016 Jul;138(1):139-49. doi: 10.1111/jnc.13382. Epub 2016 May 23. J Neurochem. 2016. PMID: 26443048 Free PMC article.
-
Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury.Restor Neurol Neurosci. 2018;36(5):659-668. doi: 10.3233/RNN-180826. Restor Neurol Neurosci. 2018. PMID: 30040768
-
Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy.Cell Physiol Biochem. 2018;49(6):2163-2173. doi: 10.1159/000493819. Epub 2018 Oct 4. Cell Physiol Biochem. 2018. PMID: 30286467
-
Neuroprotection and secondary damage following spinal cord injury: concepts and methods.Neurosci Lett. 2017 Jun 23;652:3-10. doi: 10.1016/j.neulet.2016.12.004. Epub 2016 Dec 6. Neurosci Lett. 2017. PMID: 27939975 Review.
-
Acute spinal cord injury: A review of pathophysiology and potential of non-steroidal anti-inflammatory drugs for pharmacological intervention.J Chem Neuroanat. 2018 Jan;87:25-31. doi: 10.1016/j.jchemneu.2017.08.001. Epub 2017 Aug 10. J Chem Neuroanat. 2018. PMID: 28803968 Review.
Cited by
-
Omi inhibition ameliorates neuron apoptosis and neurological deficit after subarachnoid hemorrhage in rats.Genes Genomics. 2021 Dec;43(12):1423-1432. doi: 10.1007/s13258-021-01176-y. Epub 2021 Oct 22. Genes Genomics. 2021. PMID: 34677809 Free PMC article.
-
Overexpression of the X-Linked Inhibitor of Apoptosis Protein (XIAP) in Neurons Improves Cell Survival and the Functional Outcome after Traumatic Spinal Cord Injury.Int J Mol Sci. 2023 Feb 1;24(3):2791. doi: 10.3390/ijms24032791. Int J Mol Sci. 2023. PMID: 36769152 Free PMC article.
-
Diadenosine tetraphosphate (Ap4A) inhibits ATP-induced excitotoxicity: a neuroprotective strategy for traumatic spinal cord injury treatment.Purinergic Signal. 2017 Mar;13(1):75-87. doi: 10.1007/s11302-016-9541-4. Epub 2016 Oct 19. Purinergic Signal. 2017. PMID: 27761681 Free PMC article.
-
Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway.Neurochem Res. 2019 Apr;44(4):763-775. doi: 10.1007/s11064-018-02706-z. Epub 2019 Jan 2. Neurochem Res. 2019. PMID: 30603983
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous